Economy & Markets
15 min read
Mass Spectrometry Market Poised for Growth: Reaching $10.56 Billion by 2031
GlobeNewswire
January 21, 2026•1 day ago
AI-Generated SummaryAuto-generated
The global mass spectrometry market is projected to grow from USD 7.16 billion in 2025 to USD 10.56 billion by 2031, driven by advancements in biologics characterization, food safety regulations, and AI. North America remains a dominant region, while Asia-Pacific shows significant growth. The industry is focusing on integrating software and hardware for real-time insights, despite facing challenges like capital limitations and skill shortages.
Dublin, Jan. 21, 2026 (GLOBE NEWSWIRE) -- The "Mass Spectrometry - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)" has been added to ResearchAndMarkets.com's offering. The market is segmented by Technology, Component, Application, and Geography, with market forecasts provided in terms of USD.
The Mass Spectrometry market is projected to expand from USD 7.16 billion in 2025 to USD 10.56 billion by 2031, with a CAGR of 6.68% from 2026-2031. Key drivers include increased biologics characterization, rigorous food-safety regulations, advanced AI data analytics, miniaturized point-of-care systems, and multi-omics funding.
North America remains dominant due to its established research ecosystem and regulatory framework, while Asia-Pacific's growth signals a geographical shift. The industry is moving towards integrating software with hardware to meet demands for real-time, high-throughput insights. Challenges persist with capital limitations in developing countries and a skills shortage, necessitating innovative financing and training solutions.
Evolving Biologics & Large-Molecule Characterization Needs
Ultra-high-resolution instruments are increasingly demanded as pharmaceutical companies focus on monoclonal antibodies and cell-based therapies. The market favors hybrid platforms for intricate protein workflows. Streamlining post-translational modification mapping and preserving higher-order structures are critical for capturing revenue.
Stringent Food-Safety Regulations Accelerating Adoption
The US EPA's classification of PFOA and PFOS as hazardous substances in 2024 has prompted widespread adoption of liquid chromatography-tandem mass spectrometry upgrades. In Europe, ECHA policies continue to lower detection thresholds, fostering demand for instrument installations and method development. Innovations like E-LEI-MS facilitate instantaneous pesticide identification without sample preparation, drastically cutting analysis time.
Capital-Expenditure Constraints in Academic Facilities
High-end mass spectrometry systems cost from USD 500,000 to USD 1.5 million, with ongoing expenses for maintenance and consumables eating into budgets. These financial barriers hinder upgrade cycles in developing countries' academic facilities, affecting research access and underscoring the need for cost-effective solutions.
Other Key Factors Analyzed:
Demand for Miniaturization & High-Throughput Screening in Clinical Diagnostics
Increased Multi-omics Research Funding
Experienced Mass-Spectrometrists Shortage in Emerging Markets
Segment Analysis
Hybrid models represented 46.15% of the mass spectrometry market share in 2025, while MALDI-TOF platforms are expected to grow at a 10.88% CAGR through 2031. MALDI-TOF's rapid microorganism identification significantly reduces diagnostic times, thereby decreasing hospital expenses. Advances like MALDI HiPLEX-IHC facilitate high-resolution protein imaging for oncology research. Integration with machine learning streamlines spectral-fingerprint databases, meeting increasing scalability demands.
Geography Analysis
North America held a 34.65% market share in 2025, bolstered by NIH funding, a robust biotech sector, and strict environmental regulations. The US EPA's PFAS mandates drive constant equipment updates. Asia-Pacific anticipates a 9.92% CAGR, fueled by China's venture-backed miniaturized devices and India's and South Korea's CDMO expansions. Europe remains stable, driven by stringent EFSA and EMA regulations. Middle East & Africa and South America show growth through GCC health initiatives and Brazil's agrochemical monitoring.
Companies Covered:
Agilent Technologies
Thermo Fisher Scientific
Waters Corporation
Bruker
Shimadzu
Danaher
PerkinElmer
LECO
JEOL Ltd.
Hitachi
MKS Instruments (Extrel)
Bio-Rad Laboratories
Advion Inc.
Kore Technology Ltd.
Analytik Jena GmbH
Rigaku
Teledyne FLIR (FLIR Systems)
TOFWERK AG
Hiden Analytical Ltd.
OI Analytical
Key Topics Covered
1 Introduction
1.1 Study Assumptions & Market Definition
1.2 Scope of the Study
2 Research Methodology
3 Executive Summary
4 Market Landscape
4.1 Market Overview
4.2 Market Drivers
4.3 Market Restraints
4.4 Technological Outlook
4.5 Porter's Five Forces Analysis
5 Market Size & Growth Forecasts (Value in USD)
5.1 By Technology
5.2 By Component
5.3 By Application
5.4 By Geography
6 Competitive Landscape
6.1 Market Concentration
6.2 Market Share Analysis
6.3 Company Profiles
7 Market Opportunities & Future Outlook
7.1 White-Space & Unmet-Need Assessment
For more information about this report visit https://www.researchandmarkets.com/r/juz19n
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Rate this article
Login to rate this article
Comments
Please login to comment
No comments yet. Be the first to comment!
